Medtech Insight Releases New Report on Infection Control and Biosafety Products
Aug 28, 2003
 Print this page

Medtech Insight, LLC, a provider of medical technology and market information for the medical device and investment community, announced the publication of a new market and technology report, entitled "U.S. Markets for Infection Control and Biosafety Products." This new analysis details the U.S. markets for injection devices and related products; handwashes, perioperative skin preparations, and germicides; sterilization equipment, services, and supplies; traditional and emerging wound closure devices; medical waste disposal products and services; and air filtration systems. In 2001, the combined U.S. infection control and biosafety products market totaled approximately U.S. $6.7 billion, and is expected to reach $10.3 billion in 2010, led by growth in the markets for emerging wound closure and non-skin-puncture injection devices, according to Medtech.

In addition to analyses of infection control and biosafety products, technologies, current and forecast markets, competitors, and opportunities in the U.S. for the period 2001 through 2010, the 261-page report by Medtech Insight provides an overview of infectious organisms and diseases, a discussion of infectious disease demographics and national control guidelines, and nosocomial and community-acquired infections and prevention strategies. Seventy-six exhibits and profiles of 14 key companies involved in this growing and evolving market are also included.

Back to Breaking News